Shinsuke Noguchi
Akita, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Prognostic impact of peripheral blood WT1 mRNA dynamics in patients with acute myeloid leukemia treated with venetoclax combination therapy.
Journal: International journal of clinical oncology
Published: September 27, 2023
Ovarian Follicular Lymphoma Diagnosed Due to Hydronephrosis.
Journal: Internal medicine (Tokyo, Japan)
Published: June 22, 2022
Primary breast diffuse large B-cell lymphoma in an elderly man maintaining long-term complete response
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: June 10, 2021
Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells.
Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells.
Journal: The Journal of experimental medicine
Published: June 06, 2019
Switching to nilotinib is associated with deeper molecular responses in chronic myeloid leukemia chronic phase with major molecular responses to imatinib: STAT1 trial in Japan.
Journal: International journal of hematology
Published: February 14, 2018
Dasatinib-responsive chronic lymphocytic leukemia in a patient treated for coexisting chronic myeloid leukemia.
Journal: Internal medicine (Tokyo, Japan)
Published: November 19, 2013
Adult T-cell leukemia-lymphoma developed from an HTLV-1 carrier during treatment of B-cell lymphoma-associated hemophagocytic syndrome
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: January 16, 2013
Safety and efficacy of low-dose liposomal amphotericin B as empirical antifungal therapy for patients with prolonged neutropenia.
Journal: International journal of clinical oncology
Published: April 10, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026